Cytotoxic Microspinosamides from the Marine Sponge Geodia microspinosa That Decrease Diffuse Pleural Mesothelioma Viability

Our plain-English summary of Cytotoxic Microspinosamides from the Marine Sponge Geodia microspinosa That Decrease Diffuse Pleural Mesothelioma Viability, by M. Orfanoudaki, D. Wang, L. Du, et al (Marine Drugs, 2026).

The study

• Authors: M. Orfanoudaki, D. Wang, L. Du, V. Singh, E.I. Goncharova, N. Pruett, C.D. Hoang, B.A.P. Wilson, B.R. O'Keefe
• Journal: Marine Drugs
• Published: 2026;24(9)
• Read it: PubMed · Publisher · Free full text

Abstract

A fraction from an extract of the marine sponge Geodia microspinosa was identified as active in a high-throughput screen for molecules that impair the viability of diffuse pleural mesothelioma (DPM) cell lines. Bioassay-guided isolation led to the identification of microspinosamides B and D, and a new artifact, microspinosamide C, together with two previously reported analogues, microspinosamide and polydiscamide B, as the active principles. Their planar structures were solved by NMR and HRESIMS analyses, while advanced Marfey's reaction, ROESY, and ECD were used for the establishment of their absolute configurations. All pure metabolites demonstrated low micromolar potency for the reduction in viability of the DPM cell lines.

In plain English

This was a laboratory chemistry and cell-line study. It did not study people and did not measure asbestos exposure; asbestos appears only as background in the introduction. An extract of the marine sponge Geodia microspinosa, collected in Indonesia in 1993, had been flagged in a screen for natural substances that reduce the viability of diffuse pleural mesothelioma cells. The authors isolated five related peptide compounds, worked out their chemical structures, and tested them on two patient-derived mesothelioma cell lines (MB24, sarcomatoid; MB52, epithelioid) and on a cell line model of normal pleura (NP1). Polydiscamide B and microspinosamide were the most potent. Polydiscamide B, for example, had an LD50 of 0.031 µM against MB24 cells, with a range of 0.024 to 0.038 µM shown alongside it. Two altered forms were less potent: microspinosamide C, which the authors considered a breakdown artifact, and the ring-opened microspinosamide D. All five compounds also harmed the normal pleura cells to an overlapping degree. The authors concluded that the compounds' cytotoxicity did not significantly differentiate between normal pleura and mesothelioma cells.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: Laboratory study: bioassay-guided isolation and structure determination of natural compounds from a marine sponge, followed by cell-viability testing on cell lines
• Who was studied: No human subjects. The compounds were tested on two patient-derived diffuse pleural mesothelioma cell lines, MB24 (sarcomatoid subtype) and MB52 (epithelioid subtype), and on a cell line model of normal pleura, NP1. The sponge was collected at 60 m depth in Indonesia in May 1993.
• Exposure: No asbestos exposure was studied. Cells were exposed to five sponge-derived compounds: microspinosamide B (1), microspinosamide (2), polydiscamide B (3), microspinosamide C (4) and microspinosamide D (5). Each was tested in a 10-point dose–response format, with sanguinarine chloride as a positive control for general cytotoxicity.
• Main results:
  • Polydiscamide B (3) was the most potent compound. LD50 was 0.031 µM (0.024–0.038) against MB24, 0.066 µM (0.048–0.091) against MB52 and 0.078 µM (0.058–0.105) against normal pleura NP1. The article does not say what kind of range is given in parentheses.
  • Microspinosamide (2) LD50 was 0.088 µM (0.079–0.097) against MB24, 0.250 µM (0.206–0.301) against MB52 and 0.269 µM (0.226–0.318) against NP1.
  • The new compound microspinosamide B (1) LD50 was 0.392 µM (0.309–0.493) against MB24, 0.950 µM (0.606–1.369) against MB52 and 0.670 µM (0.540–0.820) against NP1.
  • Microspinosamide C (4) was less potent. LD50 was 3.757 µM (2.814–4.884) against MB24, 5.857 µM (4.104–8.132) against MB52 and 6.077 µM (4.596–7.916) against NP1.
  • Microspinosamide D (5) was also less potent. LD50 was 1.911 µM (1.609–2.271) against MB24, 7.118 µM (6.069–8.304) against MB52 and 4.460 µM (3.666–5.521) against NP1.
  • The positive control, sanguinarine chloride, had an LD50 of 0.992 µM (0.851–1.132) against MB24, 1.058 µM against MB52 and 1.005 µM against NP1.
  • All compounds were also toxic to the normal pleura cell line NP1 to an overlapping degree, so they did not significantly distinguish normal pleura cells from mesothelioma cells.
  • Microspinosamide C (4) was regarded as a degradation artifact of microspinosamide (2) formed during purification, not a natural product of the sponge.
• The authors' conclusion: The authors concluded that microspinosamide (2) and polydiscamide B (3) were the most active compounds and that microspinosamide B (1) had similar activity. They suggested that a free N-terminus or an opened ring reduces potency, so these structural changes should be avoided to retain cytotoxicity. They also concluded that the compounds' cytotoxicity did not significantly differentiate between normal pleura and mesothelioma cells.

Topics

The National Library of Medicine indexes this study under subjects our site covers: Mesothelioma.

Medical terms in this study, explained in our Lexicon: Pleural Mesothelioma.

Related studies

• Identification of Cembrane Diterpenoids from Sinularia sp. That Reduce the Viability of Diffuse Pleural Mesothelioma Cell Lines — M. Orfanoudaki, A.F. Shaikh, et al. (2025)
• Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir — S. Catalani, F. Palma, et al. (2017)
• The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo — W. Blum, T. Henzi, et al. (2019)
• BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state — E.M. Rath, Y.Y. Cheng, et al. (2018)
• Solid-liquid Interface Screening SystemーApplication to the Screening of Antibiotic and Cytotoxic Substance-producing Fungi — S. Oda, S. Nomura, et al. (2019)
• Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma — R. Sciarrillo, A. Wojtuszkiewicz, et al. (2019)

Browse return to medical research.